Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration

Authors not listed

Chengdu Kanghong Biotech Co., Ltd. · 2011

Abstract

This study is designed to evaluate the effect of Conbercept therapy on visual acuity and anatomic outcomes and safety observed in subjects with very low vision secondary to wet age-related macular degeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2011). An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration. <em>Chengdu Kanghong Biotech Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT02098720
Vancouver
Anonymous. An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration. Chengdu Kanghong Biotech Co., Ltd.. 2011.
BibTeX
@misc{anon2011AnOpen, title = {An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration}, author = {Anonymous}, journal = {Chengdu Kanghong Biotech Co., Ltd.}, year = {2011}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings